Abbott Laboratories (NYSE:ABT) Price Target Raised to $145.00
Abbott Laboratories (NYSE:ABT – Free Report) had its price objective lifted by Stifel Nicolaus from $135.00 to $145.00 in a research report released on Thursday,Benzinga reports. The brokerage currently has a buy rating on the healthcare product maker’s stock. A number of other research analysts have also recently commented on the company. Argus raised Abbott […]
Abbott Laboratories (NYSE:ABT – Free Report) had its price objective lifted by Stifel Nicolaus from $135.00 to $145.00 in a research report released on Thursday,Benzinga reports. The brokerage currently has a buy rating on the healthcare product maker’s stock. A number of other research analysts have also recently commented on the company. Argus raised Abbott […]